The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
IL-12 Rapidly Alters the Functional Profile of Tumor-Associated and Tumor-Infiltrating Macrophages In Vitro and In Vivo
Abstract
Tumor-associated macrophages (TAMs) play a major role in promoting tumor growth and metastasis and in suppressing the antitumor immune response. Despite the immunosuppressive environment created by the tumor and enforced by tumor-associated macrophages, treatment of tumor-bearing mice with IL-12 induces tumor regression associated with appearance of activated NK cells and activated tumor-specific CTLs. We therefore tested the hypothesis that IL-12 treatment could alter the function of these tumor-associated suppressor macrophages. Analysis of tumor-infiltrating macrophages and distal TAMs revealed that IL-12, both in vivo and in vitro, induced a rapid (<90 min) reduction of tumor supportive macrophage activities (IL-10, MCP-1, migration inhibitory factor, and TGFβ production) and a concomitant increase in proinflammatory and proimmunogenic activities (TNF-α, IL-15, and IL-18 production). Similar shifts in functional phenotype were induced by IL-12 in tumor-infiltrating macrophages isolated from the primary tumor mass and in TAMs isolated from lung containing metastases, spleen, and peritoneal cavity. Therefore, although TAMs display a strongly polarized immunosuppressive functional profile, they retain the ability to change their functional profile to proinflammatory activities given the appropriate stimulus. The ability of IL-12 to initiate this functional conversion may contribute to early amplification of the subsequent destructive antitumor immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., & Suttles, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.342 · Cited by 968
Self-citationInterleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
IL‐12 and IL‐23: master regulators of innate and adaptive immunity
Langrish, C. L., McKenzie, B. S., Wilson, N. J., De Waal Malefyt, R., Kastelein, R. A., & Cua, D. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00214.x · Cited by 753
Functional plasticity of macrophages: reversible adaptation to changing microenvironments
Stout, R. D., & Suttles, J. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504272 · Cited by 751
Self-citationHesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6533 · Cited by 706
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Sinha, P., Clements, V. K., & Ostrand-Rosenberg, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.636 · Cited by 466
Tumor-induced immune dysfunction: the macrophage connection
Elgert, K. D., Alleva, D. G., & Mullins, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.275 · Cited by 426
Alternative versus Classical Activation of Macrophages
Goerdt, S., Politz, O., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., Klemke, C.-D., Dippel, E., Kodelja, V., et al. (1999) · Pathobiology · doi:10.1159/000028096 · Cited by 324
Sinha, P., Clements, V. K., & Ostrand-Rosenberg, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0045 · Cited by 317
Functional heterogeneity in liver and lung macrophages
Laskin, D. L., Weinberger, B., & Laskin, J. D. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.2.163 · Cited by 273
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250
Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors
Teague, R. M., Sather, B. D., Sacks, J. A., Huang, M. Z., Dossett, M. L., Morimoto, J., Tan, X., Sutton, S. E., Cooke, M. P., Öhlén, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1359 · Cited by 233
Nair, M. G., Cochrane, D. W., & Allen, J. E. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00225-0 · Cited by 206
Dinapoli, M. R., Calderon, C. L., & Lopez, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1323 · Cited by 204
Interleukin-15: a new cytokine target for the treatment of inflammatory diseases
MCINNES, I. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.04.003 · Cited by 172
A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis
Mordue, D. G., & Sibley, L. D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403164 · Cited by 161
Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
Tsung, K., Dolan, J. P., Tsung, Y. L., & Norton, J. A. (2002) · PubMed · Cited by 129
Nowicki, A., Szenajch, J., Ostrowska, G., Wójtowicz, A., Wójtowicz, K., Kruszewski, A. A., Maruszyński, M., Aukerman, S. L., & Wiktor-Jędrzejczak, W. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960103)65:1<112::aid-ijc19>3.0.co;2-i · Cited by 123
Hill, H. C., Conway, T. F., Sabel, M. S., Jong, Y. S., Mathiowitz, E., Bankert, R. B., & Egilmez, N. K. (2002) · PubMed · Cited by 117
Self-citationTaylor, P. R., Brown, G. D., Geldhof, A. B., Martínez‐Pomares, L., & Gordon, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200324003 · Cited by 116
IL-12: a promising adjuvant for cancer vaccination
Portielje, J. E., Gratama, J. W., van Ojik, H. H., Stoter, G., & Kruit, W. H. J. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0356-5 · Cited by 110
What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells?
Bortoluci, K. R., Marinho, C. R. F., Barboza, R., Russo, M., Álvarez, J. M., & Lima, M. R. D. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.012 · Cited by 78
Tourkova, I. L., Shurin, G. V., Chatta, G. S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3045 · Cited by 70
Critical Role for IL-15 in Innate Immunity
Ohteki, T. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362519 · Cited by 69
Hess, S. D., Egilmez, N. K., Bailey, N. A., Anderson, T. M., Mathiowitz, E., Bernstein, S. H., & Bankert, R. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.400 · Cited by 67
Self-citationIL-15: targeting CD8+ T cells for immunotherapy
Diab, A. K., Cohen, A. D., Alpdoğan, Ö., & Perales, M.-A. (2005) · Cytotherapy · doi:10.1016/s1465-3249(05)70786-6 · Cited by 40
Nair, R. E., Jong, Y. S., Jones, S. A., Sharma, A., Mathiowitz, E., & Egilmez, N. K. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000175489.19314.d2 · Cited by 38
Self-citationTumor cell-derived TGF-β and IL-10 dysregulate paclitaxel-induced macrophage activation
Mullins, D. W., Martins, R. S., Burger, C. J., & Elgert, K. D. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.1.129 · Cited by 27
Targeting the interleukin‐15 system in rheumatoid arthritis
Waldmann, T. A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21363 · Cited by 26
Some macrophages kill Listeria monocytogenes while others do not
Fleming, S. D., & Campbell, P. A. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00993.x · Cited by 26
T-Cell Signaling of Macrophage Activation: Cell Contact-Dependent and Cytokine Signals
Stout, R. D., & Suttles, J. (1996) · Medical Entomology and Zoology · Cited by 18
Self-citation
Cited by
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241
M1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,141
Sag, D., Carling, D., Stout, R. D., & Suttles, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8633 · Cited by 796
Self-citationMonocyte and Macrophage Plasticity in Tissue Repair and Regeneration
Das, A., Sinha, M., Datta, S., Abas, M., Chaffee, S., Sen, C. K., & Roy, S. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.06.001 · Cited by 743
Metadata
- Authors
- Watkins, S. K., Egilmez, N. K., Suttles, J., & Stout, R. D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-01
- Volume
- 178
- Issue
- 3
- Pages
- 1357-1362
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2151327646
- Cited by
- 273
- References
- 36
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.